Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Pandit, S., Biswas, S., Jana, U., De, R
doi: 10.1016/j.diabres.2021.108899 33 Simental-MendaLESnchez-GarcaALinden-TorresESimental-MendaM
Retatrutide adds glucagon receptor agonism to the GLP-1 and GIP targets already covered by tirzepatide, which is hypothesised to further stimulate hepatic fatty acid oxidation and lipid clearance
The blend also typically works out to better value per milligram than purchasing both compounds individually
GLP-1 agonist medications can slow digestion, reduce appetite, and improve insulin response
US$ 22.19
US$ 20.04
US$ 20.08
US$ 29.50
